Lumobiotics GmbH

Lumobiotics develops light-controllable peptide drugs as safe cytolytic agents for the treatment of solid cancers and localized infectious diseases. We are dedicated to fostering the development of chemotherapeutics based on the technology platform, utilizing molecular photoswitches.

http://Lumobiotics.com